Virtual Medicinal Product (VMP) - Acrivastine 8mg capsules

Navigation

Name Details

Name Start Date End Date
Name Current Name Acrivastine 8mg capsules Start Date 09-12-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
capsule
Unit Dose UOM
capsule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral capsule
Ontology Form/Route
capsule.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
R06AX18
BNF Start Date End Date
Current BNF 03040100 Start Date 04-04-2022 End Date
Previous BNF 03040100 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
42184011000001104 25-08-2023
320814008 09-12-2002 24-08-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Acrivastine Based on Ingredient Substance 8 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
12 capsule 366 Part VIIIA Category C
24 capsule
48 capsule
84 capsule